<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Voelzmann A</submitter><funding>Leverhulme Trust (The Leverhulme Trust)</funding><funding>UKRI | Biotechnology and Biological Sciences Research Council</funding><funding>Leverhulme Trust</funding><funding>HHS | NIH</funding><funding>Academy of Medical Sciences (The Academy of Medical Sciences)</funding><funding>Royal Society</funding><funding>Royal Society (The Royal Society)</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Academy of Medical Sciences</funding><funding>HHS | NIH (NIH)</funding><pagination>e2516746123</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12933142</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>123(8)</volume><pubmed_abstract>Glycogen Synthase Kinase 3β (GSK-3β) is a key coordinator of neuronal development and maintenance; hyperactive GSK-3β is linked to neurodevelopmental and -degenerative diseases and therefore a promising therapeutic target. In neurons, GSK-3β coordinates the cytoskeleton by phosphorylating microtubule-binding proteins. In this study, we found that tight regulation of GSK-3β kinase activity is required for the maintenance of parallel microtubule bundles in &lt;i>Drosophila&lt;/i> and rat axons. Up- or downregulation of GSK-3β led to axons forming pathological swellings in which microtubule bundles disintegrated into disorganized, curled microtubules. We identified the microtubule bundling proteins Shot and Tau as key GSK-3β targets and found that GSK-3β exerted its regulatory effect on microtubule</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>GSK-3β coordinates axonal microtubule organization through Shot and Tau.</pubmed_title><pmcid>PMC12933142</pmcid><funding_grant_id>R35GM153259</funding_grant_id><funding_grant_id>SBF008\1140</funding_grant_id><funding_grant_id>BB/P020151/1</funding_grant_id><funding_grant_id>ECF-2017-247</funding_grant_id><funding_grant_id>RGS\R2\222151</funding_grant_id><funding_grant_id>UKRI1894</funding_grant_id><funding_grant_id>BB/I002448/1</funding_grant_id><funding_grant_id>087742/Z/08/Z</funding_grant_id><pubmed_authors>Voelzmann A</pubmed_authors><pubmed_authors>Roof AE</pubmed_authors><pubmed_authors>Evans GJO</pubmed_authors><pubmed_authors>Patel S</pubmed_authors><pubmed_authors>Bentley M</pubmed_authors><pubmed_authors>Bennett H</pubmed_authors><pubmed_authors>Hahn I</pubmed_authors><pubmed_authors>Nuhu-Soso L</pubmed_authors><pubmed_authors>Adamson A</pubmed_authors></additional><is_claimable>false</is_claimable><name>GSK-3β coordinates axonal microtubule organization through Shot and Tau.</name><description>Glycogen Synthase Kinase 3β (GSK-3β) is a key coordinator of neuronal development and maintenance; hyperactive GSK-3β is linked to neurodevelopmental and -degenerative diseases and therefore a promising therapeutic target. In neurons, GSK-3β coordinates the cytoskeleton by phosphorylating microtubule-binding proteins. In this study, we found that tight regulation of GSK-3β kinase activity is required for the maintenance of parallel microtubule bundles in &lt;i>Drosophila&lt;/i> and rat axons. Up- or downregulation of GSK-3β led to axons forming pathological swellings in which microtubule bundles disintegrated into disorganized, curled microtubules. We identified the microtubule bundling proteins Shot and Tau as key GSK-3β targets and found that GSK-3β exerted its regulatory effect on microtubule</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T20:47:40.151Z</modification><creation>2026-07-10T03:12:51.313Z</creation></dates><accession>S-EPMC12933142</accession><cross_references><pubmed>41701831</pubmed><doi>10.1073/pnas.2516746123</doi></cross_references></HashMap>